U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive – CTV News

U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive  CTV NewsA powerful psychedelic plant medicine is gaining federal and state backing.  Psychology TodayIs Ibogaine the Future of Mental Health Treatment? Trump Signs Executive Order on Psychedelic Therapy; Why is this the Only Drug Named | Explained  The Sunday GuardianWhat to Know About Trump’s New Executive Order on Psychedelic Drugs  Time MagazinePresident Trump’s Landmark Order Advances Breakthrough Mental Health Treatments — Delivering New Hope to Veterans  The White House (.gov)